The author replies: To the Editor: The CASS data do indeed confirm disease probability estimates reported by Diamond and Forrester. The trend toward lower estimates in the CASS population ( fig. 1 ) most likely reflects a stricter definition for angiographic disease (70% luminal narrowing or 50% left main stenosis). Computer-assisted analysis clearly offers the potential of incorporating multiple variables into the decision process before and after sequential diagnostic test procedures within predetermined confidence limits and could provide a rapid estimate of disease probability. The CASS data show that the test procedures may be unnecessary in certain patients subsets, such as young or middle-aged women with nonspecific chest pain in whom the pretest risk of severe coronary disease is very low. The CASS report extends observations on estimates of disease severity in clinical patient subsets and we are delighted that Drs. Diamond and Forrester are able to use the data to expand the computer-assisted data base. BERNARD R. CHAITMAN 1 report in Circulation that pyrophosphate imaging is uniquely sensitive for the detection of "scattered" areas of myocardial necrosis undiagnosed by serial enzyme assays.1 They found that one-third of their patients with unstable angina had positive scintigrams. The recorded scintiscans were predominantly of the diffuse type. Positive scans correlated with ST-segment depression. I believe that their interpretation of these data is incorrect.
Creatine kinase (CK) analysis has been regarded as a reference technique for identification of acute cardiac necrosis, and in fact, enzyme levels roughly correlate with pyrophosphate infarct areas.2 Thus, these investigators need to prove that diffuse cardiac necrosis can be present with no changes in CK levels.
It is hard to understand how scattered areas of myocardial necrosis, which cannot be identified by enzymes, can, on planar imaging, appear as zones of diffuse pyrophosphate accumulation. First, acute myocardial infarction in the one-major-vessel-occlusion model is not an entity showing a random pattern. Quite the opposite: The biology of an acute cardiac infarct is one of high order.3 Forty minutes after coronary occlusion, the endocardial layer in the area at risk dies. The lateral boundary of this endocardial layer is sharply demarcated; only a few millimeters separate it from the uninvolved cardiac muscle. Over the ensuing 3-6 hours, necrosis ad-vances as a wave front to involve the area at risk in an expected transmural fashion. However, a parallel phenomenon occurs simultaneously: A network of collateral flow develops in the epicardium.4
Ten to 40% of the area at risk is spontaneously salvaged, largely where collateral flow develops.5 These events appear to be the rule in both the dog3 and in man.5 Although many aspects of pyrophosphate imaging remain controversial,6 one may advance some calculated guesses. It is likely that pyrophosphate gains access to the infarcted myocardium (and perhaps to functionally ischemic myocardium) through the developed collateral pathways just described. Two days after the onset of acute myocardial infarction, epicardial flow is still at subnormal levels.5 The radiophosphate uptake will then be predominantly epicardial. In some patients, this uptake is predominantly in the periinfarction regionsthe so-called doughnut pattern. The author replies.
To the Editor:
The present study was not designed to settle the controversy of whether pyrophosphate concentrates in ischemic as well as necrotic myocardial cells. Although we have no definitive answer to this controversy, we feel that pyrophosphate imaging in unstable angina provides useful prognostic information. Unstable angina patients with positive scintigrams have a more fulminant clinical course than patients with negative scintigrams. Based on the work of others, we believe the most likely explanation is myocardial necrosis.1`S Other possible mechanisms include persistently positive scintigrams after myocardial infarction,6 ventricular aneurysm,7 and persistent blood pool activity.8 In support of myocardial necrosis, we refer to experimental animal studies which indicate that myocardial uptake of technetium-99m pyrophosphate requires myocardial necrosis. Also, autopsy studies of patients with persistently positive scintigrams after myocardial infarction show local ongoing necrosis in the area of previous infarction.1-5 CK-MB isoenzyme analysis is clinically the most sensitive and specific technique for diagnosing myocardial necrosis. A recent study showed that myocardial necrosis is most likely, present in patients with an elevated CK-MB in the presence of normal serum CK.9 Jaffee and associates showed that the majority of unstable 642 CI RCULATION LETTERS TO THE EDITOR angina patients with positive scintigrams had enzymatic evidence for myocardial necrosis. In that study, CK-MB was assessed at a frequency that is usually not clinically indicated. In addition, CK-MB was determined by a very sensitive assay using a kinetic fluorometric assay which detects less than 1 unit per liter and thus identifies very small changes in CK-MB activity.'0 It is likely that if more frequent CK-MB determinations were obtained with this more sensitive assay in the present study, some of the patients with positive scintigrams would have had enzymatic evidence for myocardial necrosis.
We do not take issue with the excellent work of Reimer and coworkers which showed the wave front phenomenon of myocardial necrosis from the subendocardium to epicardium in experimental transmural infarction." However, we do not believe that our patients were having acute transmural infarction at the time of hospital admission, and therefore, we do not expect them to show the same wave front necrosis pattern.
Positive technetium-99m pyrophosphate myocardial scintigrams occur in approximately one-third of unstable angina patients. We agree that the mechanism is unknown. It may be due to myocardial necrosis, ischemia, or both. Our experience, as supported by other reported data, lead us to believe that low-grade myocardial necrosis is the best explanation of this phenomenon. 
Exercise Testing for Risk Stratification
To the Editor: Utilizing low-level exercise testing, Weld and colleagues have nicely added to the evaluation of risk stratification after acute myocardial infarction.' Their tables and results include data for ratios of preejection to ejection periods (PEP/LVET) that resulted in significantly adverse odds ratios for risk. However, we cannot evaluate this attractive information because nowhere in the Methods section are we told how it was obtained, i.e., using what equipment, in what posture, how long after infarction, and whether resting, during performance of exercise or after exercise? While the label "revision accepted" always suggests stringent review, authors and reviewers have overlooked an essential piece of information. DAVID 
